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Available online 1 June 2013Abstract Derivation of induced pluripotent stem (iPS) cells is mainly an epigenetic reprogramming process. It is still quite
controversial how genomic imprinting is reprogrammed in iPS cells. Thus, we derived multiple iPS clones from genetically
identical mouse somatic cells. We found that parentally inherited imprint was variably lost among these iPS clones. Concurrent
with the loss of DNA methylation imprint at the corresponding Snrpn and Peg3 imprinted regions, parental origin-specific
expression of the Snrpn and Zim1 imprinted genes was also lost in these iPS clones. This loss of parental genomic imprinting in
iPS cells was likely caused by the reprogramming process during iPS cell derivation because extended culture of iPS cells did not
lead to significant increase in the loss of genomic imprinting. Intriguingly, one to several paternal chromosomes appeared to
have acquired de novo methylation at the Snrpn and Zac1 imprinted regions in a high percentage of iPS clones. These results
might have some implications for future therapeutic applications of iPS cells. Since DNA methylation imprint can be completely
erased in some iPS clones at multiple imprinted regions, iPS cell reprogramming may also be employed to dissect the underlying
mechanisms of erasure, reacquisition and maintenance of genomic imprinting in mammals.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.Introduction
Induced pluripotent stem (iPS) cells were derived from
somatic cells directly with four transcription factors
(Oct4, Sox2, C-Myc and Klf4) (Okita et al., 2007; Takahashi
et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al.,⁎ Corresponding author.
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Open access und2007). This epigenetic reprogramming process is rapid and
stochastic (Yamanaka, 2009). Genomic imprinting is an
epigenetic phenomenon that is characterized by parental
origin-dependent expression of the imprinted genes (Barlow,
2011; Bartolomei, 2009; Bartolomei and Ferguson-Smith,
2011; Ferguson-Smith, 2011; Li, 2013). Since many imprinted
genes play an important role in development and diseases, it is
important to know whether genomic imprinting is properly
reprogrammed in iPS cells (Tomizawa and Sasaki, 2012).
About 150 imprinted genes have been discovered in
mammals so far (see http://www.mousebook.org/catalog.
php?catalog=imprinting). Some are singleton imprinted genes
(Bartolomei, 2009). Most are clustered and co-regulated by a
cis-acting imprinting control region (ICR) that ismethylated on
the maternal or paternal chromosomes (Barlow, 2011;er CC BY-NC-ND license.
862 S. Takikawa et al.Bartolomei and Ferguson-Smith, 2011; Ben-Porath and Cedar,
2000; Lewis and Reik, 2006; Li, 2013). DNA methylation
imprint at the ICRs is reset during gametogenesis (Li, 2013).
Differentially methylated region (DMR) is essential for
maintaining genomic imprinting in somatic cells. The loss of
DNA methylation imprint at the DMR results in the loss of
mono-allelic expression of the corresponding imprinted genes
in these imprinted domains (Li et al., 1993, 2008).
It is quite controversial how iPS reprogramming may affect
expression of the imprinted genes. To further examine how
genomic imprinting may be perturbed in iPS cells, we derived
multiple iPS clones from genetically identical hybrid MEF cells
carrying single nucleotide polymorphisms (SNPs) at some
imprinted regions. We analyzed DNA methylation imprint
by Combined Bisulfite Restriction Analysis (COBRA). Taking
advantage of the SNPs at two DMRs, we examined the inher-
itance of parental DNA methylation imprint at the Snrpn and
Zac1 imprinted regions in these iPS clones. In addition, we
performed allele-specific RT-PCR analysis to determine if
mono-allelic expression of the Snrpn and Zim1 imprinted
genes was retained in iPS cells and their progeny.Materials and methods
Timed mouse mating for MEF cells
The transgenic mice carrying the TetO-OSKM transgene and
the Rosa-rtTA transgene as well as the DBA/2 female mice
were obtained from the Jackson Laboratories. These two
transgenic mice were originally generated in the Jaenisch
lab (Carey et al., 2010). Timed mating was set up between
the wild-type DBA/2 female mice and the male mice that
were homozygous for the Rosa-rtTA transgene and the
TetO-OSKM transgene at the Col1A1 locus. The male mice
with the Rosa-rtTA transgene and the TetO-OSKM transgene
were primarily on a 129 genetic background (129*) based on
the information provided by the Jackson laboratories. Noon
of the day when vaginal plug was found in the female mice
was counted as half day of pregnancy. Pregnant female mice
from this cross were sacrificed at E13.5 for live embryos that
were used for deriving hybrid (DBA/129*) MEF cells carrying
a Rosa-rtTA transgene and a TetO-OSKM transgene.Derivation of iPS clones
Hybrid (DBA/129*) MEF cells carrying a Rosa-rtTA transgene
and a TetO-OSKM transgene were used for the derivation of
iPS clones. The MEF cells were plated on irradiated SNL
feeder cells at 100,000 MEF cells/10-cm dish plate with the
addition of doxycycline at a final concentration of 2 μg/ml.
ES cell medium was used for MEF cells cultured on irradiated
SNL feeder cells that constitutively express leukemia
inhibitory factor (LIF) (McMahon and Bradley, 1990). The
medium was changed every 2–3 days and 2 μg/ml of doxycy-
cline was included in the ES cell medium for 3–4 weeks until
ES cell-like iPS colonies were picked individually. After trypsin
digestion, individual iPS cell colonies were resuspended by
pipetting and plated on irradiated SNL feeder cells in one well
of a 96-well plate. When iPS cell colonies became confluent,
they were digested with trypsin. Resuspended iPS cells weretransferred to one well of a 24-well plate, and subsequently to
one well of a 6-well plate for expansion.
Three iPS clones (D15D, D36 and DL3) originated from the
hybrid OSKM/+ MEF cells plated on the irradiated feeder
cells that were derived from primary MEF cells. These three
iPS clones were expanded on the irradiated SNL feeder cells
after being picked. All other iPS clones were derived from
the hybrid OSKM/+ MEF cells plated on the irradiated SNL
feeder cells and subsequently expanded on SNL feeder cells
following the procedure described above.Culture of iPS clones on feeder cells or on
gelatin-coated plates
The standard ES cell medium was used for the iPS cell
culture. It was made of DMEM plus 15% of FCS, L-glutamine,
non-essential amino acids, β-mercaptoethanol and leukemia
inhibitory factor (LIF). The medium was changed daily. The
iPS clones were passaged once every 3–5 days when they
were grown on irradiated SNL feeder cells. They were
diluted and plated on gelatin-coated 6-well plates until the
iPS cell culture became confluent for DNA, protein or total
RNA sample preparation.Embryoid body (EB) culture
About 1–2 million of early-passage (P b 5) iPS cells grown on
irradiated SNL feeder cells were plated on non-adherent
10-cm bacterial dish plates coated with poly-hema (Sigma).
ES cell medium without LIF was used for the EB culture. The
medium was changed once every 2–3 days without removing
the aggregated EBs. Mature EBs were harvested at different
intervals from day 8 until day 16 in suspension culture for
total RNA sample preparation. They were dissolved in Trizol
reagent (Invitrogen).Bisulfite mutagenesis
Genomic DNA samples from the parental cells as well as the
iPS clones were subjected to bisulfite mutagenesis with the
EZ DNA Methylation-Gold™ Kit (Zymo Research). The bisulfite
mutagenized DNA was subjected to COBRA analysis and
bisulfite colony sequencing.Combined Bisulfite Restriction Analysis (COBRA) of
the DMR regions
PCR product was derived from the bisulfite mutagenized DNA
sampleswith the primers covering a portion of the DMR regions
(Zuo et al., 2012). The amplified bisulfite PCR product was
used for restriction digestion with the restriction enzymes
targeting the CpG sites within the DMR regions. Since the
restriction enzyme sites were lost (or gained) when the
unmethylated C was mutagenized to become U, the PCR
product from the unmethylated DNA displayed different
restriction enzyme digestion patterns on the agarose gel
than the PCR product from the methylated DNA.
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OSKM/+ (DBA/129*) E13.5 embryos 
OSKM/+ (DBA/129*) MEF cells
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on irradiated SNL feeder cells
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Expand OSKM/+ (DBA/129*) iPS colonies
A
B
+ Dox
Figure 1 A diagram is shown for the experimental procedure in
the derivation of iPS clones. A, schematic experimental proce-
dure. Timed mating was set up between the wild-type DBA/2
female mice (DBA female) and the male mice primarily on a 129
genetic background (129*) carrying the OSKM transgene at the
Col1A1 locus on both chromosomes (Carey et al., 2010). E13.5
embryos were used to derive hybrid MEF (DBA/129*) cells carrying
one copy of the OSKM transgene from the pregnant female mice.
B, an iPS clone (D15D, left panel) with similar morphology to the
wild-type TC1 ES cells (ES, right panel). The microscope images
are shown for D15D and TC1 on the irradiated SNL feeder cells.
863Genomic imprinting in iPS cellsBisulfite sequencing
The PCR product from the bisulfite mutagenized DNA samples
covering a portion of the DMR regions was cloned into the
pGEM-T vector system (Promega). Bacterial colonies were
sent for direct sequencing (Zuo et al., 2012). The sequence
result was analyzed with the web-based bisulfite DNA
sequence analysis program called QUMA (see the website:
http://quma.cdb.riken.jp/).
Allele-specific RT-PCR analysis of the imprinted
genes
RT-PCR for the Snrpn and Zim1 imprinted genes was
performed with the primers spanning at least one intron for
the total RNA samples isolated from the EBs generated with
iPS cells or from iPS cells grown on gelatin-coated plates. The
purified RT-PCR product was directly sent for sequencing to
detect the SNPs present in the original transcript for these two
imprinted genes.
Results
Established iPS clones are pluripotent
To assess how genomic imprinting is reprogrammed in iPS
cells, we employed two different strains of mice to generate
hybrid MEF cells that carry the SNPs at the imprinted regions.
A total of 12 iPS clones were derived from the hybrid (DBA/
129*) MEF cells carrying two transgenes for doxycycline-
inducible expression of the reprogramming factors (Fig. 1A).
When they were plated on the irradiated SNL feeder cells
(McMahon and Bradley, 1990), these iPS clones appeared to
have similar morphology to undifferentiated wild-type ES cells
(Figs. 1B and 1SA). All iPS clones readily formed embryoid
bodies (EBs) on non-adherent bacterial plates (Fig. 1SB).
Similar to the EBs of wild-type ES cells (Lane 3), mature EBs at
day 13 of the iPS clone L7 (Lane 7) were shown to up-regulate
the expression of two cardiac marker genes, cardiac troponin
T (cTnT) and myosin light chain 2 atrial transcripts (Mlc2a),
based on semi-quantitative RT-PCR analysis (Fig. 1SC). These
results suggest that the isolated iPS clones possess differen-
tiation potential.
The cells for these iPS clones expressed two pluripotency
marker proteins (Oct4 and Nanog) when stained with the
antibodies against these two proteins (Fig. 2SA). Expression of
Oct4was also confirmed bywestern blotting (Fig. 2SB). ZFP57, a
master regulator in genomic imprinting (Li et al., 2008; Mackay
et al., 2008), was not expressed in parental MEF cells but was
turned on in the iPS cells (Fig. 2SB). Indeed, ZFP57 is highly
enriched in undifferentiated ES cells and it maintains DNA
methylation imprint in undifferentiated ES cells as well as in
mouse (Li et al., 2008; Li and Leder, 2007; Zuo et al., 2012).
These results suggest that these iPS clones are truly repro-
grammed iPS cells that express pluripotency marker genes.
Examining paternal methylation imprint by COBRA
DNA methylation imprint for four imprinted domains is known
to be established during spermatogenesis (Li, 2013; Watanabeet al., 2011). We employed COBRA to examine the IG-DMR of
Dlk1-Dio3, the H19 DMR of Igf2-H19 and the Rasgrf1 DMR
regions in these iPS clones (Kobayashi et al., 2006).
Methylation at the IG-DMR was largely maintained
The IG-DMR, located between the Dlk1 and Gtl2 imprinted
genes, is the ICR of the Dlk1-Dio3 imprinted domain (Hiura
et al., 2007; Lin et al., 2003; Schmidt et al., 2000). Substantial
methylation was retained in most iPS clones (Lanes 5–6, 8–14
of Fig. 2A). However, little methylation was observed in two
iPS clones (Lanes 7,15 of Fig. 2A). All iPS clones were less
methylated than wild-type ES cells in Lane 16 (Fig. 2A). By
contrast, hypermethylation was observed in the parental
mouse tail samples and MEF cells (Lanes 1–4 of Fig. 2A).
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Figure 2 COBRA analysis of paternally inherited DNA methyl-
ation imprint. Genomic DNA was isolated from the iPS clones
(Lanes 5–15), mouse tail of the mother (Lane 1) and father (Lane
2), MEF cells without doxycycline (Lane 3), MEF cells with
doxycycline (Lane 4) as well as from the wild-type TC1 ES cells
(Lane 16). COBRAwas performed for three DMR regions (IG-DMR of
the Dlk1-Dio3 imprinted region, H19 DMR, Rasgrf1 DMR). The iPS
clones used for COBRA are: L7 (Lane 5), L9 (Lane 6), B11 (Lane 7),
E7 (Lane 8), D15D (Lane 9), D36 (Lane 10), C8D (Lane 11), E7D
(Lane 12), S4D (Lane 13), S5D (Lane 14) and n2 (Lane 15). U,
unmethylated product. M, methylated product. A, IG-DMR with
TaqI digestion. B, H19 DMR with ClaI digestion. C, Rasgrf1 DMR
with BstUI digestion.
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Figure 3 COBRA analysis of maternally inherited DNA methyl-
ation imprint. Genomic DNA was isolated from the iPS clones
(Lanes 5–15 for Fig. 3A–C and Lanes 5–16 for Fig. 3D–E), mouse
tail of the mother (Lane 1) and father (Lane 2), MEF cells without
doxycycline (Lane 3), MEF cells with doxycycline (Lane 4) as well
as from the wild-type TC1 ES cells (Lane 16 for A, B and C, Lane 17
for D and E). COBRA was performed for five DMR regions (Peg1,
Peg3, Snrpn, Zac1 and Peg10). The iPS clones used for COBRA are:
L7 (Lane 5), L9 (Lane 6), B11 (Lane 7), E7 (Lane 8), D15D (Lane 9),
D36 (Lane 10), C8D (Lane 11), E7D (Lane 12), S4D (Lane 13), S5D
(Lane 14), n2 (Lane 15) and DL3 (Lane 16 for D and E). U,
unmethylated product. M, methylated product. A, Peg1 DMR with
ClaI digestion. B, Peg3 DMRwith TaqI digestion. C, Snrpn DMRwith
HhaI digestion. D, Zac1 DMR with TaqI digestion. E, Peg10 DMR
with HhaI digestion.
864 S. Takikawa et al.The H19 DMR was partially methylated in most iPS
clones
The H19 DMR is the ICR for the Igf2-H19 imprinted region
(Bartolomei, 2009). Based on COBRA, substantial methylation
was observed in three iPS clones (Lanes 9–10, 13 of Fig. 2B).
Partial methylation was present in six iPS clones (Lanes 5–7,
11–12, 14 of Fig. 2B). Little methylation was observed in two
other iPS clones (Lanes 8, 15 of Fig. 2B).
Methylation at the Rasgrf1 DMR was mostly lost
Like the IG-DMR and H19 DMR,methylation at the Rasgrf1 DMR
is also inherited on the paternal chromosome (Kobayashi
et al., 2006; Watanabe et al., 2011). According to COBRA, we
found that it was partially methylated in the parental MEF
cells and mouse tail samples (Lanes 1–4 of Fig. 2C). Partial
methylation was observed in three iPS clones (Lanes 5–6, 9 of
Fig. 2C). Methylation was almost completely lost in other iPS
clones (Fig. 2C).
Taken together, these results suggest that paternally
inherited DNA methylation imprint was largely maintained atthe IG-DMR and H19 DMR regions but mostly lost at the
Rasgrf1 DMR during iPS cell derivation.
Examining maternal methylation imprint by COBRA
DNA methylation imprint at most ICRs is inherited on the
maternal chromosome (Kobayashi et al., 2006; Li, 2013). To
gauge how these ICRs were reprogrammed in iPS cells, we
analyzed five imprinted domains (Peg1, Peg3, Peg10, Snrpn
and Zac1) by COBRA.
Hypermethylation at the Peg1 DMR was stably
maintained
According to COBRA, Peg1 DMR was mostly methylated in the
parental mouse tail samples (Lanes 1–2 of Fig. 3A). This was
865Genomic imprinting in iPS cellsalso true in the hybrid MEF cells with or without doxycycline
(Lanes 3–4) and TC1 ES cells (Lane 16). This hypermethylation
was completely maintained in all iPS clones (Lanes 5–15 of
Fig. 3A). These results suggest that Peg1 DMRwas not sensitive
to demethylation during iPS reprogramming.
Methylation at the Peg3 DMR was erased in most iPS
clones
As shown in Fig. 3B, only two iPS clones in Lanes 5 and 7 had
methylation at the Peg3 DMR that was comparable to that of
TC1 ES cells (Lane 16) or the parental cells (Lanes 1–4).
Methylation was almost completely missing in other iPS clones
(Fig. 3B), suggesting that the Peg3 DMR was very sensitive to
demethylation during iPS reprogramming.
Methylation at the Snrpn DMR was variably lost in iPS
cells
Like Peg1 and Peg3 DMRs, DNA methylation imprint at the
Snrpn DMR is stably maintained on the maternal chromosome
in somatic cells. Based on COBRA, significant methylation was
observed in seven iPS clones (Lanes 5, 7–10, 12–13 of Fig. 3C).
Littlemethylation was present in three iPS clones (Lanes 6, 11,
15 of Fig. 3C). No methylation was observed in Lane 14. The
COBRA result indicates that methylation at the Snrpn DMR was
variably lost during iPS reprogramming.
The Zac1 DMR was partially methylated in some but
lost in other iPS clones
Similar to what had been observed at the Snrpn DMR region,
methylation at the Zac1 DMR was also variably lost in these iPS
clones in comparison to that of their parental cells (Fig. 3D).
Substantial methylation was present in four iPS clones (Lanes
5–6, 12–13 of Fig. 3D). Four iPS clones (Lanes 9–11, 14) were
slightly methylated at the Zac1 DMR. Little or no methylation
was observed in four iPS clones (Lanes 7–8, 15–16).
Peg10 DMR was almost completely unmethylated
As shown in Fig. 3E, parental mouse tail samples and MEF cells
displayed both methylated and unmethylated COBRA product
of the Peg10 DMR (Lanes 1–4). Peg10 DMRwas alsomethylated
in TC1 ES cells (Lane 17). However, all tested iPS clones except
two had almost no methylated COBRA product although the
iPS clone in Lane 8 failed to give rise to any bisulfite PCR
product after several tries (Fig. 3E). These results suggest that
Peg10 DMR was very sensitive to demethylation during iPS cell
derivation, similar to Peg3 DMR (Fig. 3B).
Bisulfite sequencing of four DMR regions
According to COBRA, there was significant but variable loss of
methylation at most imprinted regions in these iPS clones.
However, COBRA only analyzes one or several CpG sites
embedded within the restriction enzyme sites. It is formally
possible that methylation levels may be different at other CpG
sites. To test this possibility, we subjected the bisulfite PCR
product to bacterial colony sequencing. We sequenced twopaternal (IG-DMR of Dlk1-Dio3 and Rasgrf1) and two maternal
(Snrpn and Zac1) DMR regions. The results are illustrated
below in Figs. 3S, 4S, 4 and 5.
Bisulfite sequencing of the IG-DMR
We subjected the bisulfite PCR product for the M5 region of
the IG-DMR to bacterial colony sequencing that is a part of the
ICR for the Dlk1-Dio3 imprinted region (Takada et al., 2002).
We found that most iPS clones had significant methylation at
the M5 region of the IG-DMR although two iPS clones (n2 and
B11) had almost no methylation (Fig. 3S). Our sequencing
results were in agreement with the COBRA results. In both
assays, methylation at the IG-DMR was largely maintained but
partially lost in most iPS clones in comparison to that of the
parental MEF cells or mouse tail samples.
Bisulfite sequencing confirmed loss of methylation
at the Rasgrf1 DMR
Bisulfite PCR product covering a portion of the Rasgrf1 DMR
region was sent for bacterial colony sequencing (Kobayashi
et al., 2006; Watanabe et al., 2011). As shown in Fig. 4SA,
parental mouse tail samples and MEF cells were similarly
methylated at the Rasgrf1 DMR region. Two iPS clones (L9 and
DL3) had close to normal methylation and three (E7, L7 and
D15D) had partial methylation at this DMR (Fig. 4SB). But it
was largely missing in other seven iPS clones (Fig. 4SB). The
sequencing results were generally consistent with the COBRA
result for this DMR region (Fig. 2C).
Bisulfite sequencing of the Snrpn DMR
In our previous study, we had utilized SNPs within the Snrpn
DMR to distinguish its parental origin (Li et al., 2008).
Similarly, we confirmed the presence of the SNPs within the
Snrpn DMR in these iPS clones by direct sequencing of the
genomic DNA samples for these iPS clones as well as their
parental cells. Then we determined the parental origin of the
methylated or unmethylated Snrpn DMR after bisulfite
sequencing. As expected, both methylated and unmethylated
Snrpn DMR with the ratio close to 1:1 was present in the
parental mouse tail samples (Fig. 4A). In the parental MEF
cells, only the maternal chromosome with the DBA/2 origin
contained the methylated Snrpn DMR whereas the paternal
chromosome with a 129 origin did not have any methylated
Snrpn DMR (Fig. 4A). Doxycycline had no effect onmethylation
at the Snrpn DMR in parental MEF cells (Fig. 4A). However,
methylation at the Snrpn DMR on the maternal chromosome
was variably lost in these iPS clones (Fig. 4B–D). It was largely
intact in three iPS clones (B11, E7D, L7) although there was
already some loss of maternal methylation imprint at the
Snrpn DMR even in these three iPS clones (Fig. 4B). Maternal
methylation imprint was partially maintained in four iPS
clones (S4D, D15D, D36 and DL3) (Fig. 4C). Maternally derived
DNA methylation imprint at the Snrpn DMR was completely
missing in other iPS clones (L9, C8D, E7, S5D and n2) (Fig. 4D).
In general, the Snrpn COBRA results correlated with the
bisulfite sequencing data for these iPS clones except for E7
(compare Figs. 3C and 4). Although significant methylation
was found for E7 by COBRA (Lane 8 of Fig. 3C), not many
Mother Father MEF MEF + Dox
M M
A
P P
B
B11
M
P
E7D
M
L7
M
P P
D36S4D D15D
C
M
P
M
M
P
DL3
M
P
P
L9 E7
D
M
P
S5DC8D
M
M
M
n2
M
P
P
P
P
Figure 4 Maternally inherited DNA methylation imprint was variably lost at the Snrpn DMR in iPS clones. Bacterial colony
sequencing of the bisulfite PCR product was performed for genomic DNA samples from the parental cells as well as from the iPS clones
at early passages (bP5). Filled circle, methylated CpG. Unfilled circle, unmethylated CpG. Cross (X), CpG site without a clear
methylation status. Each row stands for a sequenced DNA template molecule from a single bacterial colony. M, maternal chromosome
with an “A” at the nucleotide position 267 and a “T” at the nucleotide position 275 of the 471-bp bisulfite PCR product with a DBA/2
origin. P, paternal chromosome with a “G” at the nucleotide position 270 and another “G” at the nucleotide position 278 of the
474-bp bisulfite PCR product with a 129 origin. A, bisulfite sequencing results for the parental cells. Mother, mouse tail of the mother.
Father, mouse tail of the father. MEF, MEF cells. MEF + Dox, MEF cells cultured with doxycycline. B, three iPS clones (B11, E7D and
L7) with relatively high methylated Snrpn DMR on the maternal chromosome (M). C, four iPS clones (S4D, D15D, D36 and DL3) with
partially methylated Snrpn DMR on the maternal chromosome (M). D, five iPS clones (L9, C8D, E7, S5D and n2) with unmethylated
Snrpn DMR on the maternal chromosome (M).
866 S. Takikawa et al.methylated DNA molecules were discovered for E7 by
bisulfite sequencing (Fig. 4D). This discrepancy was due to
an abnormally high percentage of methylation at the CpG
within the target site of restriction enzyme HhaI used in
COBRA (see the 9th CpG site of the analyzed Snrpn DMR in E7
of Fig. 4D). Interestingly, some iPS clones appeared to have
one (B11, D36, L9, C8D, E7 and n2) or two (DL3) methylated
Snrpn DMR carrying a SNP that would be expected to bederived from a paternal chromosome of the 129 origin rather
than from a maternal chromosome of the DBA/2 origin
(Figs. 4B–D).
Some iPS clones were cultured on SNL feeder cells until
Passage 20 (P20). Then iPS cells at P20 were grown on
gelatin-coated plates before being harvested for bisulfite
sequencing. We found that the maternal Snrpn DMR became
somewhat more methylated in the iPS clone L7 at P20 than it
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Figure 5 Maternally inherited DNA methylation imprint was variably lost at the Zac1 DMR region in the iPS clones. Bacterial colony
sequencing of the bisulfite PCR product was performed for genomic DNA samples from the parental cells as well as from the iPS clones
at early passages (bP5). Filled circle, methylated CpG. Unfilled circle, unmethylated CpG. Cross (X), CpG site without a clear
methylation status. Each row stands for a sequenced DNA template molecule from a single bacterial colony. M, maternal chromosome
with a “G” at the nucleotide position 169 of the 317-bp bisulfite PCR product with a DBA/2 origin. P, paternal chromosome with an
“A” at the nucleotide position 169 of the 317-bp bisulfite PCR product with a 129 origin. A, bisulfite sequencing results for the
parental cells. Mother, mouse tail of the mother. Father, mouse tail of the father. MEF, MEF cells. MEF + Dox, MEF cells cultured with
doxycycline. B, six iPS clones (L7, E7D, D15D, S4D, C8D and L9) with partially methylated Zac1 DMR on the maternal chromosome (M).
C, six iPS clones (B11, E7, S5D, D36, n2 and DL3) with unmethylated Zac1 DMR on the maternal chromosome (M).
867Genomic imprinting in iPS cellswas at earlier passage (compare Fig. 5SA with Fig. 4B).
However, methylation was somewhat reduced in E7D and
completely lost in S4D at P20 (Fig. 5SA), whereas E7D was
relatively highly methylated and S4D was partially methyl-
ated at early passages (bP5) (Figs. 4B–C). Compared to early
passages (Fig. 4D), methylation remained absent or largely
lost at the Snrpn DMR on the maternal chromosome in other
iPS clones (E7, L9 and S5D) at P20 (Fig. 5SA). These results
suggest that partially methylated Snrpn DMR may be more
dynamic than unmethylated or fully methylated Snrpn DMR.
Methylation can be either increased or decreased at a
partially methylated Snrpn DMR.Bisulfite sequencing of the Zac1 DMR
We identified a SNP at the Zac1 DMR that allowed us to
determine its parental origin. As shown in Fig. 5, maternally
inherited DNA methylation imprint at the Zac1 DMR was also
variably lost in these iPS clones. Parental mouse tail samples
contained about 40% of methylated and 60% of unmethylated
Zac1 DMR (Fig. 5A). As expected, only the maternal chromo-
some of the DBA/2 origin was methylated at the Zac1 DMR in
the hybrid (DBA/129*) MEF cells with or without doxycycline.
Six iPS clones (L7, E7D, D15D, S4D, C8D and L9) displayed
partial loss of methylation at the maternal Zac1 DMR (Fig. 5B),whereas methylation was completely lost at the maternal
Zac1 DMR in six other iPS clones (B11, E7, S5D, D36, n2 and
DL3) (Fig. 5C).
Bisulfite sequencing of the Zac1 DMR confirmed the COBRA
results for all iPS clones except for D15D (compare Fig. 3D with
Fig. 5). Many methylated DNA molecules were discovered for
D15D by bisulfite sequencing (Fig. 5B), but little methylated
product was identified by COBRA (Lane 9 of Fig. 3D). This
discrepancy was caused by almost a complete absence of
methylation at the second CpG site of the analyzed Zac1 DMR
in D15D (Fig. 5B). This CpG site was the target site of TaqI and
that was why there was very little methylated product by
COBRA (Lane 9 of Fig. 3D). Intriguingly, a fewmethylated Zac1
DMR carried a SNP of an apparent 129 origin rather than one of
an apparent DBA/2 origin (Figs. 5B and 5C).
We also analyzed the Zac1 DMR for some iPS clones at P20
by bisulfite sequencing. We found that maternal DNA
methylation imprint was partially maintained at the Zac1
DMR in four iPS clones (L7, L9, S4D and E7D) (Fig. 5SB).
Methylation was completely lost in two iPS clones (E7 and
S5D) at P20 (Fig. 5SB). Compared to those at early passages,
DNA methylation imprint was somewhat increased for L9 at
P20 and reduced for E7D and S4D at P20 (compare Fig. 5 with
Fig. 5SB). It remained almost the same for L7, E7 and S5D at
P20 (compare Fig. 5 with Fig. 5SB). Again, it seems that
partially methylated Zac1 DMR in the iPS clones L9, E7D and
MEF MEF+Dox
100%G 100%G
B11
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90%G
E7D
60%G
E7
75%G
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55%G
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50%G
DL3
50%G
A
B
Figure 6 RT-PCR analysis of the Snrpn imprinted gene in MEF
cells as well as in embryoid bodies (EBs) derived from the iPS cells.
Total RNA was isolated from MEF cells and EBs derived from 12 iPS
clones generated from the hybrid MEF cells. Typically, iPS clones
at earlier passages (P b 5) were used for EB derivation and mature
EBs were harvested between day 12 and day 16 in suspension
culture for total RNA preparation. The RT-PCR product of normally
paternally expressed Snrpn imprinted gene was generated from
these total RNA samples and subjected to direct sequencing after
agarose gel purification. A portion of the sequencing result
containing the SNP of the Snrpn imprinted gene is shown for
each sample, together with the part of the chromatogram that
harbors the SNP. The estimated percentage of G nucleotide at the
SNP underneath the chromatogram indicates the percentage of
the Snrpn transcript that was transcribed from the paternal 129
allele of Snrpn in EBs of each iPS clone or in the parental hybrid
MEF cells. The maternal allele of Snrpnwith a DBA/2 origin has a T
at the corresponding nucleotide position. A, sequencing results for
the parental MEF cells as well as two iPS clones (B11 and L7) that
displayed almost exclusive expression from the paternal allele of
Snrpn. MEF, MEF cells. MEF + Dox, MEF cells cultured in the
presence of doxycycline. B, sequencing results for ten other iPS
clones that showed partial or complete bi-allelic expression of
Snrpn.
868 S. Takikawa et al.S4D was more dynamic during extended culture than highly
methylated Zac1 DMR in L7 or unmethylated Zac1 DMR in E7
and S5D.
Allele-specific expression analysis of imprinted
genes
After sequencing genomic DNA samples, we found that there
is a SNP in an exon of two imprinted genes (Snrpn and Zim1)
in these iPS clones that are located in the Snrpn and Peg3
imprinted regions, respectively. However, we did not find
any SNP in the exons of other imprinted genes located in the
imprinted regions that were examined in this study. These
SNPs allowed us to distinguish whether the transcript for
Snrpn and Zim1 was transcribed from the maternal allele of
a DBA/2 origin or from the paternal allele of a 129 origin.
RT-PCR analysis of the Snrpn imprinted gene
Snrpn is usually transcribed from its paternal allele at the
Snrpn imprinted region in somatic cells. Indeed, we found
that it was exclusively expressed from the paternal allele in
the MEF cells regardless of doxycycline (Fig. 6A). Total RNA
isolated from mature EBs of these iPS clones was subjected
to RT-PCR analysis. Two iPS clones (B11 and L7) retained this
paternal allele-specific expression of the imprinted Snrpn
gene and 90% or more of the transcript for Snrpn was
expressed from the paternal allele carrying the SNP of a 129
origin (Fig. 6A). Snrpn was preferentially (70% or more of the
transcript) expressed from the paternal allele in three iPS
clones (E7, C8D and S4D) (Fig. 6B). However, the rest of
these iPS clones either displayed only slight preference for
the paternal allele (60–65%G for D15D, E7D, D36 and L9) or
were almost completely bi-allelic (50–55%G for S5D, n2 and
DL3) with respect to the expression of Snrpn (Fig. 6B).
We also isolated total RNA from iPS clones directly plated
on gelatin-coated plates from early (bP5) to late passages
(P20). We analyzed a few iPS clones at earlier passages (P3–
P5) (Fig. 6S). Indeed, Snrpn was exclusively expressed from
the paternal allele in B11 (100%G, 129 origin), and preferen-
tially expressed from the paternal allele in L7 (85%G), E7
(80%G) and E7D (80%G) (Fig. 6S). The expression for Snrpn
became more or less bi-allelic for four iPS clones (S4D, D15D,
L9 and S5D), ranging from 50%G to 60%G of the transcript with
a 129 origin (Fig. 6S).
We cultured a few iPS clones until P20. The expression
patterns of Snrpn for these iPS clones were similar to those of
EBs or iPS clones at earlier passages (see Figs. 6, 6S and 7S). In
the iPS clone L7 at P20, Snrpn was exclusively expressed from
the paternal allele (100%G of a 129 origin) (Fig. 7S). It was
preferentially expressed from the paternal allele in E7D at P20
(80%G) (Fig. 7S). Partial bi-allelic expression was observed in
E7 (65%G), S4D (65%G), D36 (60%G), L9 (60%G), S5D (60%G), n2
(60%G) and DL3 (55%G) (Fig. 7S).
RT-PCR analysis of the Zim1 imprinted gene
Zim1 in the Peg3 imprinted region is maternally expressed in
somatic cells. Indeed, it was exclusively expressed from the
maternal allele in the MEF cells irrespective of doxycycline
(Fig. 7A). When differentiated as EBs, complete maternal
MEF
100% G
MEF+Dox
100% G
B11
80% G
E7D
75% G
L7
100% G
S4D
100% G
D36
85% G
L9
45% G
C8D
40% G
S5D
45% G
DL3
50% G
n2
40% G
D15D
40% G
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Figure 7 RT-PCR analysis of the Zim1 imprinted gene at the Peg3 imprinted region in MEF cells as well as in EBs. Total RNA was
isolated from MEF cells and EBs derived from 12 iPS clones. Typically, iPS clones at earlier passages (P b 5) were used for EB
derivation and mature EBs were harvested between day 12 and day 16 in suspension culture for total RNA preparation. The RT-PCR
product of normally maternally expressed Zim1 imprinted gene was sent for direct sequencing after agarose gel purification. The
estimated percentage of G nucleotide at the SNP underneath the chromatogram indicates the percentage of the Zim1 transcript that
was transcribed from the maternal DBA/2 allele in EBs of each iPS clone or in the parental hybrid MEF cells. The paternal allele of
Zim1 with a 129 origin has an A at the corresponding nucleotide position. A, sequencing results for the parental hybrid MEF cells as
well as five iPS clones that displayed exclusive (L7 and S4D) or preferential (D36, B11 and E7D) mono-allelic expression from the
maternal allele of Zim1. MEF, MEF cells. MEF + Dox, MEF cells cultured with doxycycline. B, sequencing results for seven other iPS
clones that showed almost complete bi-allelic expression of Zim1.
869Genomic imprinting in iPS cellsallele-specific expression of Zim1 was observed in two iPS
clones (L7 and S4D, both 100%G) (Fig. 7A). It was preferen-
tially expressed from the maternal allele of Zim1 in three
other iPS clones (85%G for D36, 80%G for B11 and 75%G for
E7D) (Fig. 7A). Bi-allelic expression of Zim1 was observed in
the rest of iPS clones (40–50%G) (Fig. 7B).
We examined the expression of Zim1 in some iPS clones
that were directly plated on gelatin-coated plates after being
grown on feeder cells. Out of eight iPS clones examined at
early passages (within P5) (Fig. 8S), only B11 still maintained
somewhat maternal allele-specific expression of Zim1 (75%G
at P5). Bi-allelic expression of Zim1was observed in the rest of
iPS clones at early passages (40–50%G) (Fig. 8S).
We also analyzed allele-specific expression of Zim1 in iPS
clones at P20 plated on gelatin-coated plates. Only L7
retained some maternal allele-specific expression of Zim1
(75%G) (Fig. 9S). All other iPS clones became bi-allelic at P20
(40–50%G) (Fig. 9S).Discussion
Our comprehensive DNA methylation analysis in many iPS
clones has demonstrated that parentally inherited DNA
methylation imprint was variably lost at many imprintedregions in iPS cells (Table 1S). Some imprinted regions such as
the paternally inherited Rasgrf1 DMR andmaternally inherited
Peg3 and Peg10 DMRs were more susceptible to this presum-
ably genome-wide demethylation process during iPS cell
reprogramming (Figs. 2, 3 and 4S). Except for one or two iPS
clones, most iPS clones had no or very little DNA methylation
imprint retained in these three imprinted regions based on
COBRA and bisulfite sequencing analyses. DNA methylation
imprint was relatively more stably maintained in the mater-
nally inherited Peg1 DMR and the paternally inheritedH19DMR
and IG-DMR of the Dlk1-Dio3 imprinted region (Figs. 2 and 3).
Indeed, Peg1 DMR seemed to be properly methylated in all iPS
clones examined in this study. Whereas several iPS clones had
lost methylation, most iPS clones had partial or close to
normal levels of methylation at the H19 DMR and IG-DMR
(Figs. 2 and 3S). By contrast, methylation was variably lost at
the Snrpn DMR and Zac1 DMR in almost all iPS clones isolated in
this study (Figs. 3–5). These results suggest that different
imprinted regions may possess different mechanisms in
maintaining DNA methylation imprint.
Several iPS clones retained most of maternally inherited
DNA methylation imprint at either the Snrpn or Zac1 or both
DMR regions. For example, maternally inherited DNA
methylation imprint was largely intact at both the Snrpn
and Zac1 DMR regions in the iPS clone L7 (Figs. 4B and 5B).
870 S. Takikawa et al.The iPS clone B11 only retained DNA methylation imprint at
the Snrpn but not at the Zac1 DMR (Figs. 4B and 5C). Some
iPS clones maintained partial methylation at one or both
DMR regions. The rest of them had completely lost the
maternally inherited DNA methylation imprint at either the
Snrpn or Zac1 or both DMRs. These results also indicate that
independent epigenetic mechanisms may be present at
different imprinted regions in the maintenance of parental
DNA methylation imprint.
Most iPS clones (8 out of 12) used in this study were derived
from the same population of MEF cells that were originated
from a single mouse embryo. Thus, they were genetically
identical. However, significant difference was observed
among these eight iPS clones in maintaining parental DNA
methylation imprint during reprogramming of iPS cells. Four
other iPS clones (S4D, D15D, D36 and S5D) were derived from
the MEF cells of another embryo. These four genetically
identical iPS clones also exhibited variable loss of methylation
at both Snrpn and Zac1 DMRs (Figs. 4–5) as well as other
imprinted regions (Figs. 2–3). These results suggest that this
variable loss of DNA methylation imprint at different
imprinted regions was likely caused by the variations in
epigenetic reprogramming during the derivation of iPS cells.
It has been reported previously that Dlk1-Dio3 imprinted
domain may be hypermethylated in iPS clones (Liu et al.,
2010; Stadtfeld et al., 2010, 2012). However, hyper-
methylation at the IG-DMR of the Dlk1-Dio3 region was found
to be mainly caused by different expression levels of
transgenes used for iPS cell derivation in another study
(Carey et al., 2011). The iPS clones we derived with the
transgenes developed by the Jaenisch laboratory did not
display any hypermethylation at the IG-DMR either (Figs. 2A
and 3S). In fact, the IG-DMR was somewhat hypomethylated in
most iPS clones we isolated compared with that of the
parental cells as well as the wild-type TC1 ES cells. Several
iPS clones may have lost methylation at the IG-DMR. These
results suggest that the dosage of the reprogramming factors
as well as culture conditions may contribute to the variations
of DNA methylation at the Dlk1-Dio3 imprinted region among
different studies.
Interestingly, we found that IG-DMR was hypermethylated
in the MEFs and mouse tail cells in comparison to ES cells
(Figs. 2A and 3SA). This may be a result of IG-DMR imprinting in
a tissue-specific manner. Indeed, it had been reported before
that IG-DMR is hypermethylated in postnatal neural stem cells
(NSCs) and niche-astrocytes but differentially methylated on
the paternal chromosome in embryonic NSCs (Ferron et al.,
2011). Likewise, IG-DMR may not be imprinted in MEFs or
in mouse tail, meaning that both maternal and paternal
IG-DMR regions are partially or completely methylated. But
it is imprinted in ES cells and only the paternal IG-DMR
is methylated. That is why we found IG-DMR exhibited
hypermethylation in the MEF and mouse tail samples,
compared with about 50% of methylation in the ES cell sample
(Fig. 3SA). It has been documented that pluripotent stem cells
obtained via iPS reprogramming harbor more residual DNA
methylation signatures of the parental somatic cells than
nuclear-transfer-derived pluripotent stem cells (Kim et al.,
2010). Thus, it is possible that some iPS clones isolated with
certain approaches may have retained more parental imprint-
ing memory at this Dlk1-Dio3 imprinted region than other iPS
clones derived with other approaches.We generated multiple iPS clones from the hybrid MEF
cells derived from the cross between a DBA/2 female mouse
and a 129 male mouse. The SNPs between these two mouse
strains allowed us to distinguish the parental origins of
several ICRs. Indeed, we found that maternally inherited
DNA methylation imprint at both the Snrpn and Zac1 DMRs
was partially or completely lost in all iPS clones examined.
Even for several iPS clones with relatively high methylation
levels at these two DMR regions, partial loss of maternally
inherited DNA methylation imprint was still evident. These
results indicate that DNA methylation imprint is susceptible
to the genome-wide demethylation process during iPS
derivation. Thus, an approach using iPS cell derivation may
be employed to dissect the underlying mechanism in the
maintenance and erasure of genomic DNA methylation
imprint in somatic cells.
Curiously, one or two DNA molecules carrying the SNPs of
an apparent 129 origin were methylated at the Snrpn or Zac1
DMR based on bisulfite sequencing data (Figs. 4, 5 and 5S). This
could mean that DNA methylation imprint was established de
novo on the paternal chromosome for these two imprinted
regions during iPS cell derivation. Alternatively, the DNA
molecules containing the SNPs of a 129 origin could come from
the trace amount of contaminated genomic DNA of the SNL
feeder cells carried over with the iPS cells when they were
diluted onto the gelatin-coated plates for genomic DNA
isolation. However, only a small number of feeder cells were
typically transferred to the gelatin-coated plates and the
irradiated feeder cells did not proliferate because of
radiation-induced cell cycle arrest. By contrast, iPS cells
proliferate rapidly. We usually did not harvest the iPS cells on
gelatin-coated plates for DNA preparation until they reached
confluency. Thus, it is unlikely that the carryover feeder cells
would comprise a significant portion of the iPS cell culture on
gelatin-coated plates before genomic DNA preparation.
Therefore, we would favor the first model that de novo
methylation occurred on the paternal chromosome for these
two imprinted regions in a small percentage of iPS cells. We
hypothesize that this may have occurred immediately after
the original parental DNA methylation imprint was erased
during the process of iPS cell derivation from the MEF cells.
This suggests that some aspects of the iPS reprogramming
process may mimic what happens in the germ line during the
resetting of DNA methylation imprint. If that is the case, it
might be possible to manipulate genomic imprinting in vitro
so that human cells with genomic imprinting defect can be
fixed in iPS cells before being put back into human patients for
cell-based therapies. It also indicates that iPS reprogramming
can be harnessed as an approach to dissect the underlying
mechanisms in the establishment of DNA methylation imprint.
The results for allele-specific RT-PCR analysis of both Snrpn
and Zim1 imprinted genes are consistent with the DNA
methylation analysis of these two ICRs in most iPS clones
with a few notable exceptions. The iPS cloneswithmore intact
DNA methylation imprint had the tendency to maintain the
preferential mono-allelic expression patterns of both
imprinted genes. This was true for Snrpn in the iPS cells at
early-passage (bP5), late-passage (P20) or in EBs (Figs. 6, 6S
and 7S). Indeed, two iPS clones (B11 and L7) that had retained
most of the maternally derived DNA methylation imprint
maintained mono-allelic expression of Snrpn at all tested
stages as well as in EBs (Figs. 6A, 6SA and 7S).
871Genomic imprinting in iPS cellsAlthough it had maintained most of the original DNA
methylation imprint at early passages (Fig. 4B), the iPS clone
E7D did not showmuchmono-allelic expression of Snrpn in EBs
derived from the iPS cells at early passages (Fig. 6B).
Interestingly, Snrpn was more preferentially expressed from
the paternal allele in the iPS cells of E7D grown on
gelatin-coated plates at P5 or P20 (Figs. 6SA and 7S). This
suggests that some imprinting marks other than DNA methyl-
ation imprint (such as histone modifications) might have been
lost in E7D when differentiated as EBs. Consistent with this,
maternally derived DNA methylation imprint was not stably
maintained at the Snrpn DMR in E7D during its extended
culture on feeder cells (compare Fig. 4B with Fig. 5SB).
However, the expression of Snrpn in E7D at P20 was almost
identical towhat it was at P5 (80%G for E7D in both Figs. 6S and
7S). Even more intriguingly, Snrpn was preferentially
expressed from the paternal allele in EBs as well as in iPS
cells at early passages for the iPS clone E7 even though it had
lost almost all maternally inherited DNA methylation imprint
at the Snrpn DMR (see Figs. 6B, 6S and 4D). These results imply
that other imprinting marks such as histone modifications may
preserve the preferential mono-allelic expression patterns of
the imprinted genes even when DNA methylation imprint may
be compromised at the Snrpn imprinted region. Indeed, there
is DNA methylation-independent imprinting memory at the
Snrpn DMR in mouse embryos based on our previously
published study (Li et al., 2008). It will be interesting to find
out the nature of imprinting memory at the Snrpn DMR that
maintains the mono-allelic expression patterns of the
imprinted genes. In this regard, the iPS clones E7 and E7D
may serve as useful model systems for dissecting out this kind
of imprinting memory in the future.
Zim1 in the Peg3 imprinted region seemed to be more
preferentially expressed from the maternal allele for four iPS
clones (L7, S4D, D36 and E7D) in the cells differentiated as EBs
than in the iPS cells differentiated on gelatin-coated plates
(compare Fig. 7Awith Figs. 8S and 9S). Thus, Zim1 appeared to
be more inclined to be preferentially expressed from the
maternal allele in EBs for these iPS clones. This means that the
imprinting marks for mono-allelic expression of Zim1 may be
stabilized during EB differentiation. Interestingly, little DNA
methylation imprint was detected in three iPS clones (S4D,
D36 and E7D) based on COBRA (Fig. 3B), suggesting that there
may be DNA methylation-independent imprinting memory at
the Peg3 DMR region as well. Indeed, imprinted regulation at
the Peg3 DMR appears to be quite unusual. It was recently
reported that deleting a fragment of 2.5 kb within the Peg3
DMR surprisingly had no effect on the methylation at this
imprinted domain in the progeny carrying this deletion
irrespective of its parental origin (Kim et al., 2012). This
hints that chromatin marks or other epigenetic factors may be
involved in maintaining differential DNA methylation as well
as mono-allelic expression of the imprinted genes at the Peg3
imprinted region. Interestingly, the methylated maternal
Peg3 DMR was thought to be non-functional at some stages
but functional at other stages of development (Kim et al.,
2012). Thus, it is possible that maternal Peg3 DMR may be
non-functional in undifferentiated iPS or ES cells but it
becomes functional when differentiated as EBs. As a result,
Zim1 was largely bi-allelically expressed in almost all iPS
clones in the undifferentiated state but it was preferentially
expressed from the maternal allele in 5 out of 12 iPS cloneswhen differentiated as EBs (compare Fig. 7 with Figs. 8S and
9S).
It was reported before that genomic imprinting was also
variably lost in the mouse ES cell lines derived via nuclear
transfer (nt) (Humpherys et al., 2001). Similar to what we
found with the iPS clones in this study, expression of the
Peg1 imprinted gene appeared to be stably maintained in
ntES clones whereas methylation at the H19 DMR as well as
the expression of Igf2 and H19 imprinted genes were variably
affected in ntES clones (Humpherys et al., 2001). Expression
of Peg3 and Snrpn was reported to be less affected in ntES
clones. In contrast, methylation at the Peg3 DMR was largely
missing and methylation at the Snrpn DMR was variably lost
in iPS clones. Mono-allelic expression of the Snrpn and Peg3
imprinted genes was also variably lost in mouse iPS clones,
concurrent with the loss of DNA methylation imprint at
these two imprinted regions. Thus, reprogramming via ntES
cells shares some similarities to iPS reprogramming. Both
reprogramming processes will result in a variable loss of
genomic imprinting at some common imprinted regions. At
least one imprinted region (Peg1) seems to be resistant to
reprogramming. But other imprinted regions exhibit differ-
ent susceptibilities with some being more sensitive to one
reprogramming process than the other or vice versa. This
implies that epigenetic modifiers may be differentially
expressed in these two systems so that differential loss of
imprinting was observed at some imprinted regions.Conclusions
Genomic imprinting is absolutely essential for the embryonic
development in mammals including humans (Barlow, 2011;
Bartolomei and Ferguson-Smith, 2011; Li, 2013). Improper
expression of the imprinted genes causes a variety of human
diseases (Das et al., 2009; Mackay et al., 2008; Robertson,
2005; Tomizawa and Sasaki, 2012). For instance, the Snrpn
imprinted region is associated with Prader-Willi and Angelman
Syndromes (Horsthemke and Wagstaff, 2008; Jiang et al.,
1998; Kantor et al., 2006; Mabb et al., 2011). About 20% of the
cases of transient neonatal diabetes have been linked with
hypomethylation at the Zac1/PLAGL1 imprinted region in
humans (Mackay et al., 2008). Based on this study, both
imprinted regions suffered variable loss of maternally
inherited DNA methylation imprint. In addition, the Snrpn
imprinted gene lost its normal paternal allele-specific expres-
sion pattern and became more or less bi-allelic in most iPS
clones. We also found that DNA methylation imprint was
almost completely missing in most iPS clones at some
imprinted regions such as Rasgrf1, Peg3 and Peg10 DMRs
(Figs. 2C, 3B and 3E). Consistent with our findings in mouse iPS
cells, genomic imprinting defect has been shown to be present
in human iPS cells as well (Nazor et al., 2012; Pick et al.,
2009). Therefore, caution must be taken in assessing whether
certain iPS clones are properly reprogrammed to have normal
developmental potentials if the imprinting status of all
imprinted regions has not been thoroughly examined. Future
research focused on how genomic imprinting is reprogrammed
during iPS cell derivation may lead to eventual production of
therapeutically suitable iPS cells.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.05.011.
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